Developments in lncRNA reducing myocardial ischemia/reperfusion injury

doi:10.20039/j.cnki.10073949.2023.06.012

Home > Archive>Volume 31, Issue 6, 2023 >539-545. DOI:10.20039/j.cnki.10073949.2023.06.012

Developments in lncRNA reducing myocardial ischemia/reperfusion injury
DOI:
                        10.20039/j.cnki.10073949.2023.06.012
                    
CSTR:
                        
                    
Author:
                        CHENG JiaoCHENG Jiao
Institute of Cardiovascular Diseases, University of South China & Key Laboratory for Arteriosclerology of Hunan Province & International Scientific and Technological Innovation Cooperation Base for Arteriosclerotic Diseases in Hunan Province, Hengyang, Hunan 421001, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
XIE JiaxinXIE Jiaxin
Institute of Cardiovascular Diseases, University of South China & Key Laboratory for Arteriosclerology of Hunan Province & International Scientific and Technological Innovation Cooperation Base for Arteriosclerotic Diseases in Hunan Province, Hengyang, Hunan 421001, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
LIU ChenLIU Chen
Institute of Cardiovascular Diseases, University of South China & Key Laboratory for Arteriosclerology of Hunan Province & International Scientific and Technological Innovation Cooperation Base for Arteriosclerotic Diseases in Hunan Province, Hengyang, Hunan 421001, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
HUANG JiHUANG Ji
Institute of Cardiovascular Diseases, University of South China & Key Laboratory for Arteriosclerology of Hunan Province & International Scientific and Technological Innovation Cooperation Base for Arteriosclerotic Diseases in Hunan Province, Hengyang, Hunan 421001, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
WEI XingWEI Xing
Institute of Cardiovascular Diseases, University of South China & Key Laboratory for Arteriosclerology of Hunan Province & International Scientific and Technological Innovation Cooperation Base for Arteriosclerotic Diseases in Hunan Province, Hengyang, Hunan 421001, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:Institute of Cardiovascular Diseases, University of South China & Key Laboratory for Arteriosclerology of Hunan Province & International Scientific and Technological Innovation Cooperation Base for Arteriosclerotic Diseases in Hunan Province, Hengyang, Hunan 421001, China)
Clc Number:R5；R363
Fund Project:

Article

Figures

Metrics

Reference

Cited by

Materials

Comments

Abstract:

Long non-coding RNA (lncRNA) is a class of RNA more than 200 nucleotides long and has no protein-coding capacity, but it plays a very important role in regulating various biological processes such as proliferation, apoptosis, migration, invasion and differentiation. It has found that lncRNA is closely related to the development of myocardial ischemia/reperfusion (I/R) injury. This review discusses the advances in the reduction of myocardial I/R injury and its possible mechanisms by lncRNA.

Key words:long non-coding RNA; myocardial ischemia/reperfusion injury; oxidative stress; autophagy; inflammatory response; apoptosis

Get Citation

CHENG Jiao, XIE Jiaxin, LIU Chen, HUANG Ji, WEI Xing. Developments in lncRNA reducing myocardial ischemia/reperfusion injury[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(6):539-545.

Copy

Article Metrics

Abstract:
PDF:
HTML:
Cited by:

History

Received:October 14,2022
Revised:December 26,2022
Adopted:
Online: June 12,2023
Published:

Policies & Instructions

Get Citation

Share

Article Metrics

History

Article QR Code